{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:22:47Z","timestamp":1790079767791,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,8,8]],"date-time":"2010-08-08T00:00:00Z","timestamp":1281225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00108-010-2594-5","type":"journal-article","created":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T04:33:18Z","timestamp":1281155598000},"page":"1127-1135","source":"Crossref","is-referenced-by-count":9,"title":["Heparininduzierte Thrombozytopenie","Heparin-induced thrombocytopenia"],"prefix":"10.1007","volume":"51","author":[{"given":"T.","family":"Thiele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Althaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,8]]},"reference":[{"key":"2594_CR1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","volume":"355","author":"Arepally","year":"2006","unstructured":"Arepally GM, Ortel TL (2006) Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355:809\u2013817","journal-title":"N Engl J Med"},{"key":"2594_CR2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.1H569","volume":"41","author":"Beiderlinden","year":"2007","unstructured":"Beiderlinden M, Treschan TA, Gorlinger K, Peters J (2007) Argatroban anticoagulation in critically ill patients. Ann Pharmacother 41:749\u2013754","journal-title":"Ann Pharmacother"},{"key":"2594_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0038-1651610","volume":"69","author":"Chong","year":"1993","unstructured":"Chong BH, Burgess J, Ismail F (1993) The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 69:344\u2013350","journal-title":"Thromb Haemost"},{"key":"2594_CR4","unstructured":"Chong BH, Magnani H (2007) Danaparoid for the treatment of heparin-induced thrombocytopenia. In: Heparin-induced thrombocytopenia. Informa Healthcare 295\u2013318"},{"key":"2594_CR5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V83.6.1535.1535","volume":"83","author":"Chong","year":"1994","unstructured":"Chong BH, Murray B, Berndt MC et al (1994) Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 83:1535\u20131541","journal-title":"Blood"},{"key":"2594_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrc.2009.12.006","volume":"25","author":"Crowther","year":"2010","unstructured":"Crowther MA, Cook DJ, Albert M et al; Canadian Critical Care Trials Group (2010) The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care 25: 287\u2013293","journal-title":"J Crit Care"},{"key":"2594_CR7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1345\/aph.1G738","volume":"40","author":"Efird","year":"2006","unstructured":"Efird LE, Kockler DR (2006) Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. Ann Pharmacother 40:1383\u20131387","journal-title":"Ann Pharmacother"},{"key":"2594_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0037-1614536","volume":"81","author":"Eichler","year":"1999","unstructured":"Eichler P, Budde U, Haas S et al (1999) First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4\/heparin ELISA. Thromb Haemost 81:625\u2013629","journal-title":"Thromb Haemost"},{"key":"2594_CR9","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood.V96.7.2373","volume":"96","author":"Eichler","year":"2000","unstructured":"Eichler P, Friesen HJ, Lubenow N et al (2000) Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood 96:2373\u20132378","journal-title":"Blood"},{"key":"2594_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1538-7836.2009.03385.x","volume":"7","author":"Greinacher","year":"2009","unstructured":"Greinacher A (2009) Heparin-induced thrombocytopenia. J Thromb Haemost 7 (Suppl 1):9\u201312","journal-title":"J Thromb Haemost"},{"key":"2594_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0037-1617144","volume":"30","author":"Greinacher","year":"2010","unstructured":"Greinacher A, Althaus K, Krauel K, Selleng S (2010) Heparin-induced thrombocytopenia. Hamostaseologie 30:17\u201320","journal-title":"Hamostaseologie"},{"key":"2594_CR12","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","volume":"5","author":"Greinacher","year":"2007","unstructured":"Greinacher A, Juhl D, Strobel U et al (2007) Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 5:1666\u20131673","journal-title":"J Thromb Haemost"},{"key":"2594_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1213\/ane.0b013e31817b65c2","volume":"107","author":"Greinacher","year":"2008","unstructured":"Greinacher A, Levy JH (2008) HIT happens: diagnosing and evaluating the patient with heparin-induced thrombocytopenia. Anesth Analg 107:356\u2013358","journal-title":"Anesth Analg"},{"key":"2594_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/RPE753J4PMG9773Q","volume":"127","author":"Janatpour","year":"2007","unstructured":"Janatpour KA, Gosselin RC, Dager WE et al (2007) Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia. Am J Clin Pathol 127:429\u2013433","journal-title":"Am J Clin Pathol"},{"key":"2594_CR15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","volume":"72","author":"Kelton","year":"1988","unstructured":"Kelton JG, Sheridan D, Santos A et al (1988) Heparin-induced thrombocytopenia: laboratory studies. Blood 72:925\u2013930","journal-title":"Blood"},{"key":"2594_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0049-3848(00)00303-0","volume":"100","author":"Lindhoff-Last","year":"2000","unstructured":"Lindhoff-Last E, Piechottka GP, Rabe F, Bauersachs R (2000) Hirudin determination in plasma can be strongly influenced by the prothrombin level. Thromb Res 100:55\u201360","journal-title":"Thromb Res"},{"key":"2594_CR17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","volume":"4","author":"Lo","year":"2006","unstructured":"Lo GK, Juhl D, Warkentin TE et al (2006) Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 4:759\u2013765","journal-title":"J Thromb Haemost"},{"key":"2594_CR18","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1538-7836.2005.01623.x","volume":"3","author":"Lubenow","year":"2005","unstructured":"Lubenow N, Eichler P, Lietz T, Greinacher A (2005) Lepirudin in patients with heparin-induced thrombocytopenia \u2013 results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost 3:2428\u20132436","journal-title":"J Thromb Haemost"},{"key":"2594_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00063030-200014020-00005","volume":"14","author":"Lubenow","year":"2000","unstructured":"Lubenow N, Greinacher A (2000) Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudin. BioDrugs 14:109\u2013125","journal-title":"BioDrugs"},{"key":"2594_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0091270009350626","volume":"50","author":"Nafziger","year":"2010","unstructured":"Nafziger AN, Bertino JS (2010) Desirudin dosing and monitoring in moderate renal impairment. J Clin Pharmacol 50:614\u2013622","journal-title":"J Clin Pharmacol"},{"key":"2594_CR21","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","volume":"97","author":"Pouplard","year":"2001","unstructured":"Pouplard C, Iochmann S, Renard B et al (2001) Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 97:3300\u20133302","journal-title":"Blood"},{"key":"2594_CR22","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","volume":"107","author":"Rauova","year":"2006","unstructured":"Rauova L, Zhai L, Kowalska MA et al (2006) Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 107:2346\u20132353","journal-title":"Blood"},{"key":"2594_CR23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.CCM.0000259538.02375.A5","volume":"35","author":"Selleng","year":"2007","unstructured":"Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35:1165\u20131176","journal-title":"Crit Care Med"},{"key":"2594_CR24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMp068309","volume":"356","author":"Warkentin","year":"2007","unstructured":"Warkentin TE (2007) Drug-induced immune-mediated thrombocytopenia \u2013 from purpura to thrombosis. N Engl J Med 356:891\u2013893","journal-title":"N Engl J Med"},{"key":"2594_CR25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1160\/TH07-11-0693","volume":"99","author":"Warkentin","year":"2008","unstructured":"Warkentin TE, Greinacher A, Koster A (2008) Bivalirudin. Thromb Haemost 99:830\u2013839","journal-title":"Thromb Haemost"},{"key":"2594_CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","volume":"135","author":"Warkentin","year":"2001","unstructured":"Warkentin TE, Kelton JG (2001) Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135:502\u2013506","journal-title":"Ann Intern Med"},{"key":"2594_CR27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","volume":"344","author":"Warkentin","year":"2001","unstructured":"Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286\u20131292","journal-title":"N Engl J Med"},{"key":"2594_CR28","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMp068309","volume":"356","author":"Warkentin","year":"2007","unstructured":"Warkentin TE, Maurer BT, Aster RH (2007) Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 356:2653\u20132655","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-010-2594-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2594-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T03:31:12Z","timestamp":1591759872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-010-2594-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,8]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1007\/s00108-010-2594-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,8]]}}}